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Abstract
The prevalence of myopia is constantly on a rise. Patients with high myopia 
and pathological myopia can lose vision due to a number of degenerative changes 
occurring at the macula. With recent advances in imaging techniques such as 
spectral domain optical coherence tomography (OCT) and swept-source OCT, our 
understanding of macular pathology in myopia has improved significantly. New 
conditions such as myopic traction maculopathy have been identified and defined. 
Treatment approaches are now being planned on the basis of the pathoanatomy of 
myopic traction maculopathy on OCT. In this chapter, we discuss the role of OCT 
imaging in myopic traction maculopathy.
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1. Introduction
Myopic traction maculopathy was first described by Panozza and associates in 
2004 as a group of pathological features seen in eyes with high myopia generated 
by traction [1]. In recent times, MTM is also termed as myopic foveoschisis. One of 
the important reasons for reduced vision in these myopic eyes is traction-related 
retinal disorders. Eyes with myopic traction maculopathy demonstrate features of 
vitreomacular traction, retinal thickening, macular retinal schisis-like thicken-
ing, lamellar macular hole (MH), and foveal retinal detachment (FRD)[2]. Many 
of these retinal pathologies are not detectable on clinical examination and are 
only found on advanced imaging with optical coherence tomography. Because of 
the clinical subtlety of some of these disorders, decreased visual acuity may be 
attributed to other causes, whereas macular traction may remain undiagnosed 
[3–8]. The natural course of myopic macular traction disorders is not clear. Some 
studies have shown progression to more serious complications like full-thickness 
MH and FRD while a few studies have shown spontaneous resolution of foveal 
detachment and macular retinoschisis after development of spontaneous posterior 
vitreous detachment (PVD) [6, 9–13]. Optical coherence tomography (OCT) is a 
useful, non-invasive and indispensable tool in the diagnosis, pathogenesis, staging, 
prognosis, treatment and follow-up of MTM. In this article, we describe the role of 
OCT imaging in MTM.
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2. Pathogenesis
Before the advent of OCT, the anatomic features of MTM were not described 
and the pathogenesis was poorly understood. Both TD-OCT and SD-OCT studies 
have provided an invaluable contribution to the characterization and under-
standing of the underlying pathologic mechanism involved in MTM. There are 
four major traction mechanisms identified in MTM: (1) Peri foveal vitreomacular 
traction (2) Cortical vitreous remnants after (PVD) development (3) Epiretinal 
membrane formation (4) Intrinsic non-compliance of the internal limiting 
membrane (ILM) and inner retina to conform to the shape of the posterior 
staphyloma [14, 15]. The first three mechanisms constitute the extrinsic forces 
(outside the retina) responsible for MTM while the stiff ILM and inner retinal 
layers constitute the intrinsic force (within the retina) responsible for MTM 
formation. The ILM itself can cause traction in eyes with posterior staphyloma. 
Figure 1. 
Mechanisms causing MTM. (a) MTM caused by vitreomacular traction with presence of foveal retinal 
detachment (FRD). (b) Epiretinal membrane causing schisis-like retinal thickening with associated FRD.  
(c) MTM with no apparent preretinal membranes. (d) Tenting of the inner retina at the retinal arteriole 
(black arrow) with complete resolution of the retinal thickening following vitrectomy in MTM.
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It appears that in eyes without identifiable preretinal tractional elements, ILM 
peeling resolves the retinal thickening. There are two possible explanations: One 
is that the ILM is highly elastic and tough, rendering it taut like a drum. In eyes 
with posterior staphyloma, the ILM is like the surface of a drum and is relatively 
resistant to permanent deformation and stretching. The second, more probable, 
explanation is that microscopic cellular and collagen proliferation develops on 
the ILM surface after PVD causing the ILM to be less distensible and making 
it more rigid. This prevents the ILM to conform to the contour of the posterior 
staphyloma and causes a schisis-like retinal thickening [16]. Understanding the 
pathogenetic mechanism responsible for MTM formation helps in deciding the 
surgical approach in these eyes (Figure 1).
3. Diagnosis
Myopic tractional maculopathy is virtually seen in eyes with posterior staphy-
loma. In a study using SD-OCT, Henaine-Berra et al. [17] identified MTM in 17 
of 116 eyes of pathological myopia, thus reporting a prevalence of approximately 
15%. Some of these retinal changes are difficult to appreciate in eyes with high 
myopia due to the presence of the pathological degenerative changes at the 
posterior pole. Decreased visual acuity in these eyes is usually attributed to 
causes other than macular traction. OCT is often used in identifying the differ-
ent retinal pathologies like vitreomacular traction, retinal thickening, macular 
retinoschisis, lamellar MH, and FRD. Progression of the myopic tractional 
detachment to develop a full-thickness MH and macular retinal detachment can 
also be identified with use of OCT.
4. Staging and classification
On the basis of OCT, Shimada et al. [4] have classified MTM into five stages 
from S0 to S4. This staging is based on the location of retinoschisis and its extent of 
macular involvement (Table 1).
Shimada et al. [4] further defined the progression as an increase of the extent or 
height of retinoschisis (more than 100 μm) or the development of an inner lamellar 
MH, FRD, or full-thickness MH. During a mean follow-up of 36.2 months, they 
reported progression in 11.6% (24/207) eyes, which included 0.9% who progressed 
to full-thickness MH and 3.4% who progressed to FRD. The eyes with extensive 
macular retinoschisis (S4) showed progression significantly more (42.9%) than 
eyes having less extensive macular retinoschisis areas (6.7%). Six (21.4%) of 28 eyes 
with S4 MTM progressed to foveal detachment (Figures 2 and 3).




3 Both foveal and extrafoveal but not the entire macula
4 Entire macula
Table 1. 
Staging of myopic tractional maculopathy depending on the extent of involvement.
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Figure 3. 
(a–c) Progression of MTM in the fellow eye of a patient who had undergone vitrectomy for MTM with foveal 
detachment in the other eye.
Figure 2. 
(a–d) Progression of MTM leading to FRD over a period of 5 years.
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5. Treatment
The goal of treatment in MTM is to relieve the tractional forces responsible 
for the formation of MTM [18]. This can be achieved primarily with the help of 
internal procedure with vitrectomy and external procedure with macular buckle. 
Pharmacologic vitreolysis can be considered a useful treatment option if vitreomac-
ular traction from the perifoveal PVD or traction associated with a remnant cortical 
vitreous layer after PVD is responsible for the MTM formation.
The indications of surgery in MTM are:
1. Recent onset reduction in visual acuity secondary to development of full-
thickness MH or FRD.
2. Progression in the extent of the schisis-like thickening documented by OCT.
3. Vision <20/50.
Most surgeons while dealing with myopic traction maculopathy have two 
approaches:
1. Minimalist approach—This involves identifying and resolving only the major 
traction mechanism visible on OCT. In this approach, only vitrectomy with 
PVD induction is carried out. ILM peeling is not done in these cases. This 
avoids complications of ILM peeling in select eyes, but it is unlikely to be suc-
cessful in each and every case.
2. Comprehensive approach—In this approach, all the preretinal tractional ele-
ments are removed along with ILM peeling in every case. This approach has the 
highest single-operation success rate and ensures complete removal of all cel-
lular and vitreous components that might cause current or future traction [14].
Taniuchi et al. [19] evaluated the effect of vitrectomy with and without ILM 
peeling in 71 eyes of 64 patients with myopic traction maculopathy. They studied 
the effects on visual acuity and post-operative complications. The results indicated 
that vitrectomy with ILM peeling can lead to improvement in vision in patients 
with macular retinoschisis or foveal detachment. Recurrences of tractional macular 
detachment were also more frequent in eyes without ILM peeling.
5.1 Surgical techniques
Basically, vitrectomy with removal of the posterior cortical vitreous is what is 
minimally required in relieving the tractional forces responsible for MTM forma-
tion. The role of additional procedures like peeling of internal limiting membrane 
and use of gas tamponade in MTM is debatable. In eyes with MTM secondary to 
vitreomacular traction from the perifoveal PVD and traction associated with a 
remnant cortical vitreous layer after PVD, vitrectomy alone with removal of pos-
terior cortical vitreous is sufficient in relieving the traction and achieves a normal 
retinal anatomy. In eyes with MTM secondary to epiretinal membrane formation, 
additional removal of epiretinal membrane is required. MTM caused by intrinsic 
stiffening of the ILM requires peeling of ILM with or without the placement of 
macular buckle [20, 21]. Few studies have shown that sparing a small island of ILM 
over the fovea in eyes with MTM can prevent the development of post-operative 
MHs which are usually difficult to fix [22, 23] (Table 2).
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Common difficulties encountered during vitrectomy in these high myopic eyes 
are: (1) inability of the smaller gauge instruments to reach the retinal tissue at the 
macula due to longer axial length; (2) In eyes with posterior staphyloma, the vitreous 
is strongly adherent to the edge of the staphyloma resulting in retinal breaks during 
PVD induction; (3) Staining of ILM with various dyes is usually inadequate and 
patchy making ILM peeling difficult in these scenarios; (4) Glaucoma is associated 
with high myopia resulting in an already compromised optic nerve head which can 
get worsened following vitrectomy; (5) Scleral thinning associated with high myopia 
Figure 4. 
(a–b) Pre and post-operative images of a patient with myopic foveoschisis with FRD. At 6 months post-op, 
there is complete resolution of the retinal thickening and subretinal fluid.
MTM Surgery procedure
(1) Due to vitreomacular traction from the 
perifoveal PVD
Vitrectomy with posterior cortical vitreous removal
(2) Due to traction associated with a remnant 
cortical vitreous layer after PVD
Vitrectomy with posterior cortical vitreous removal
(3) Due to epiretinal membrane formation Vitrectomy with posterior cortical vitreous removal 
with ERM removal
(4) Due to intrinsic stiffening of the ILM (a) Vitrectomy with posterior cortical vitreous removal 
with ILM peeling
(b) Macular buckle alone
(c) combined vitrectomy and macular buckle
(5) With associated full-thickness MH or FRD (a) Vitrectomy with posterior cortical vitreous removal 
with ILM peeling with gas tamponade
(b) Macular buckle alone
(c) Combined vitrectomy and macular buckle
Abbreviations: MTM—myopic traction maculopathy; PVD—posterior vitreous detachment; ERM—epiretinal 
membrane; ILM—Internal limiting membrane; MH—Macular hole; FRD—Foveal retinal detachment.
Table 2. 
Surgical decision-making in myopic traction maculopathy based on pathoanatomy seen on optical coherence 
tomography.
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can lead to catastrophic complications like expulsive hemorrhage. Thus, macular 
buckle has emerged as a useful and effective treatment option in the management of 
MTM. However, due to the longer learning curve of this technique and unpredictable 
outcomes following this procedure, vitrectomy still remains the most preferred treat-
ment modality amongst most vitreoretinal surgeons in the management of MTM.
6. Monitoring
Following surgery for MTM, resolution of retinal thickening and/or foveal 
detachment is monitored using OCT. Complete resolution of retinal thickness or 
subretinal fluid is achieved in 6–9 months after surgery [24] (Figure 4). Patients 
with high myopia and unilateral MTM require regular OCT monitoring of the fel-
low eye to assess progression to myopic pre-MTM [25].
7. Conclusion
One of the important causes for disturbed vision secondary to high myopia is 
MTM. It may be difficult to appreciate MTM on clinical examination with biomi-
croscopy. With the advent of OCT, the diagnosis of MTM and a posterior staphy-
loma can be made easily. Newer generation OCT imaging modalities have helped 
in the understanding the mechanism of myopic foveoschisis formation and help 
in deciding the treatment plan by the retinal surgeon. Early detection and referral 
to a retinal specialist for evaluation and treatment when appropriate may prevent 
further vision loss secondary to MH formation and/or retinal detachment.
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